financetom
Business
financetom
/
Business
/
Zai Lab Secures Hong Kong Medical Regulator Approval for Cervical Cancer Treatment
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Zai Lab Secures Hong Kong Medical Regulator Approval for Cervical Cancer Treatment
Sep 2, 2025 1:16 AM

03:53 AM EDT, 09/02/2025 (MT Newswires) -- Zai Lab ( ZLAB ) said late Monday that the Hong Kong Department of Health has approved Tivdak for the treatment of adults with recurrent or metastatic cervical cancer.

The drug is currently under regulatory review in China, the company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved